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Purpose
To evaluate extracts from two medical plants Pao Per-
eira (Pao) and Rauwolfia vomitoria (Rau) for their anti-
tumor effects in various types of pancreatic cancers and
ovarian cancers.
Methods
Five pancreatic cancer and three ovarian cancer cell
lines were tested that exhibited different resistance to
the 1st line chemo-drug gemcitabine (Gem, for pancrea-
tic cancer), and carboplatin (Cp, for ovarian cancer).
Chou-Talalay’s method was used to evaluate drug
combination.
Results
Both Rau and Pao extracts induced dose-dependent
cytotoxicities in all tested cancer cell lines, despite their
inherent resistance to chemo-drugs. IC50 values for Rau
were 140-350µg/ml, and 120-350µg/ml for Pao, depend-
ing on the cells tested. Normal epithelial cell MRC-5
was much less affected compared to all the tested cancer
cells. The differences of cell viabilities between cancer
cells and normal cells were statistically significant
(p<0.05), indicating possible low toxicity of these
extracts. To test whether the treatments of Rau or Pao
could enhance the cells’ sensitivities to chemo-drugs, we
combined either Rau or Pao with gemcitabine to treat
pancreatic cancer cells, and with carboplatin to treat
ovarian cancer cells. The combination treatments took
Chou-Talalay’s constant ratio design, with molar ratio
set to IC50extract: IC50Chemo. The combined-treatments
significantly enhanced cell death in cancer cells which
were strongly resistant to gemcitabine or carboplatin
(p<0.05). The results showed a left-shift in the dose-
response curves of the combination treatments
compared to the corresponding curves with either Gem
or Cp alone in all tested cancer cells. Combination
indices (CIs) were <1, indicating synergistic effects.
Conclusion
These results pave the way for in vivo studies of the
anti-cancer effects of Rauwolfia vomitoria and Pao Per-
eira extracts, especially in gemcitabine-resistant pancrea-
tic cancers and carboplatin-resistant ovarian cancers.
Studies on mechanisms of the anti-cancer actions are
also undergoing concerning apoptosis and cell cycle
arrests.
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